2025³â 06¿ù 21ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Intelsat Completes Satellite Life-Extension Mission, Makes Space History

´º½ºÀÏÀÚ: 2025-04-25


Mission Extension Vehicle 1 (MEV-1) safely departs from Intelsat 901 (IS-901) in the Geosynchronous Earth Orbit (GEO) after providing five years of life extension service. The earth is visible in the background as well as MEV-1’s docking mechanism on the right. (Courtesy: Northrop Grumman’s Space Logistics)

MCLEAN, VA. -- Intelsat, operator of one of the world’s largest integrated satellite and terrestrial networks, became the first and only satellite operator to complete a life-extension mission adding five years of valuable service to the Intelsat 901 (IS-901) satellite and its many customers, providing extended reliable and global connectivity.

“The MEV mission proved that in-orbit servicing enhances satellite sustainability and efficiency in space,” said Jean-Luc Froeliger, SVP of Space Systems, Intelsat. “We were able to provide five additional years of reliable service to our Network, Media and Mobility customers and paved the way for future advancements in satellite servicing.”

The world’s first Mission Extension Vehicle (MEV), developed by Northrop Grumman Corporation’s (NYSE: NOC) Space Logistics LLC, successfully detached from IS-901 after moving the satellite to the graveyard orbit, where the satellite will be decommissioned after nearly 24 years of service. The MEV first docked with IS-901 in February of 2020 nearly 19 years after the satellite was first launched.

Geostationary satellites use propellant to remain at a specific orbital location, relocate to a new location or eventually be moved to a graveyard orbit. The MEV has its own propellant and thrusters that operate independently of the satellite. Through in-orbit docking, the MEV allows Intelsat to extend the life of a satellite by several years when the original propellant of that satellite has been depleted.

“Using the MEV to extend the life of IS-901 was a great commercial success for our customers, as well as a historic technical achievement,” Froeliger said. “We had to do a rendezvous and approach of two spacecraft moving at 3km per second,” Froeliger said.

Following this success, Intelsat partnered with Northrop Grumman on a second mission in 2021, using MEV-2 to extend the life of Intelsat 10-02, a combination that remains operational today. Intelsat continues to seek out and invest in next-generation satellite life-extension projects and other innovation setting the stage for continued advancements and enabling emerging space companies to shape the future of the industry.



 Àüü´º½º¸ñ·ÏÀ¸·Î

KIOXIA and Linus Media Group Set World Record for Pi Calculation
Medisca Secures Settlement With FlackTek, Reinforcing Patent Strength of MAZ¢ç Mixer
Capvidia Expands Model-Based Definition (MBD) Interoperability with QIF-Enabled NX Software
VeriSilicon¡¯s Ultra-Low Energy NPU Provides Over 40 TOPS for On-Device LLM Inference in Mobile Applications
FiberStar Selects Incognito Software Systems to Optimize Fiber Network and Enhance Wi-Fi Service Quality
Smart Factory: Ushering in a New Era of Manufacturing Open share list
Yokogawa Announces Release of Next-Generation of the CENTUM VP Integrated Production Control System

 

Faraday Unveils FlashKit¢â-22RRAM: An eNVM-Based SoC Development Platf...
Innoviva Specialty Therapeutics Gains FDA Acceptance for Zoliflodacin,...
HistoSonics and Cambridge University Unveil Europe¡¯s First Edison¢â H...
Fujirebio Announces Strategic Collaboration with Stanford Medicine to ...
IQM¡¯s State of Quantum 2025: Quantum Industry Must Solve Talent Short...
Novotech Showcased in Global Biotech Series for Innovation in Hepatiti...
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complem...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..